Yizhen Li

ORCID: 0000-0001-8941-6691
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Chronic Myeloid Leukemia Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • DNA Repair Mechanisms
  • Pancreatic and Hepatic Oncology Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Risks and Factors
  • Multiple and Secondary Primary Cancers
  • Global Cancer Incidence and Screening
  • Cancer, Lipids, and Metabolism
  • Liver Disease Diagnosis and Treatment
  • Liver physiology and pathology
  • Single-cell and spatial transcriptomics
  • Immunotherapy and Immune Responses
  • Food Quality and Safety Studies
  • Garlic and Onion Studies
  • Insect-Plant Interactions and Control
  • Hepatocellular Carcinoma Treatment and Prognosis
  • GABA and Rice Research
  • Gout, Hyperuricemia, Uric Acid
  • Traditional Chinese Medicine Studies
  • Protein Degradation and Inhibitors

Soochow University
2024-2025

First Affiliated Hospital of Henan University
2025

First Affiliated Hospital of Zhengzhou University
2022-2025

State Key Laboratory of Genetic Engineering
2025

Fudan University
2025

St. Jude Children's Research Hospital
2019-2024

Second Affiliated Hospital of Xi'an Jiaotong University
2021-2024

Shenyang Pharmaceutical University
2023-2024

Guangzhou University of Chinese Medicine
2022-2023

Beihang University
2023

Introduction This study aimed to describe the latest epidemiology of female breast cancer globally, analyze change pattern incidence rates and disease’s association with age, period, birth cohort, subsequently present a forecast incidence. Methods Data for analysis were obtained from Global Burden Disease (GBD) Study 2019 World Population Prospects revision by United Nations (UN). We described age-standardized (ASIRs) 1990 then calculated relative risks period cohort using an...

10.3389/fonc.2022.891824 article EN cc-by Frontiers in Oncology 2022-06-09

Leukemia can arise at various stages of the hematopoietic differentiation hierarchy, but impact developmental arrest on drug sensitivity is unclear. Applying network-based analyses to single-cell transcriptomes human B cells, we define genome-wide signaling circuitry for each cell stage. Using this reference, comprehensively map states acute lymphoblastic leukemia (B-ALL), revealing its strong correlation with asparaginase, a commonly used chemotherapeutic agent. Single-cell multi-omics...

10.1016/j.ccell.2024.03.003 article EN cc-by-nc-nd Cancer Cell 2024-04-01

The process of searching for and selecting clinical evidence systematic reviews (SRs) or guidelines is essential researchers in Traditional Chinese medicine (TCM). However, this often time-consuming resource-intensive. In study, we introduce a novel precision-preferred comprehensive information extraction selection procedure to enhance both the efficiency accuracy TCM practitioners. We integrated an established deep learning model (Evi-BERT combined rule-based method) with Boolean logic...

10.1186/s12874-024-02430-z article EN cc-by-nc-nd BMC Medical Research Methodology 2025-01-15

Long noncoding RNA HOX antisense intergenic myeloid 1 (HOTAIRM1) has been characterized as a critical factor in all-trans retinoic acid (ATRA)-induced differentiation of acute promyelocytic leukemia (APL) cells. However, the essential transcription for gene expression HOTAIRM1 is still unknown. Chromatin immunoprecipitation (ChIP) assays revealed that PU.1 constitutively bound to regulatory region HOTAIRM1. Co-expression led transactivation reporter assay. Detailed analysis showed two...

10.1186/s13045-016-0274-1 article EN cc-by Journal of Hematology & Oncology 2016-05-04

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and can arise B or T lymphoid lineages. Although risk loci have been identified for B-ALL, inherited basis of T-ALL mostly unknown, with a particular paucity genome-wide investigation susceptibility variants large patient cohorts.

10.1093/jnci/djz043 article EN JNCI Journal of the National Cancer Institute 2019-03-25

Background: Exposure to ambient particulate matter pollution (APMP) is a global health issue that directly affects the human respiratory system. Thus, we estimated spatiotemporal trends in burden of APMP-related diseases from 1990 2019. Methods: Based on Global Burden Disease Study 2019, data were analyzed by age, sex, cause, and location. Joinpoint regression analysis was used analyze temporal different over 30 years. Results: Globally, APMP contributed most chronic obstructive pulmonary...

10.3389/fpubh.2021.740800 article EN cc-by Frontiers in Public Health 2021-11-23

CRISPR/Cas9-mediated genome editing has the potential to delete PD-L1 both on cell surface and inside cell, thereby inhibiting tumor growth migration overcoming immunosuppression. ZG16, with its lectin structure, can reduce expression surface. However, direct comparison of two approaches in Pancreatic ductal adenocarcinoma (PDAC) cells not yet been investigated. In this study, we established Panc-1 line: one knockout another ZG16 overexpression. Both methods promoted polarization...

10.3389/fimmu.2025.1510179 article EN cc-by Frontiers in Immunology 2025-01-31

Summary Improving plant architecture and increasing yields are the main goals of rice breeders. However, yield is a complex trait influenced by many yield‐related traits. Identifying characterizing important genes in coordinated network regulating traits their interactions conducive to cultivating high‐yielding varieties. In this study, we determined that interaction between mitogen‐activated protein kinase kinase5 (OsMAPKKK5) brassinosteroid‐signalling kinase1–1 (OsBSK1–1) regulates rice....

10.1111/pbi.70008 article EN cc-by-nc-nd Plant Biotechnology Journal 2025-02-18

Genetic alterations in the RUNX1 gene are associated with benign and malignant blood disorders, particularly of megakaryocyte myeloid lineages. The role acute lymphoblastic leukemia (ALL) is less clear, how germline genetic variation influences predisposition to this type leukemia. Sequencing 4,836 children B-ALL 1,354 cases T-ALL, we identified 31 18 variants, respectively. variants consistently showed minimal damaging effects. By contrast, 6 T-ALL-related result drastic loss activity as a...

10.1172/jci147898 article EN Journal of Clinical Investigation 2021-06-24

Blinatumomab is an efficacious immunotherapeutic agent in B cell acute lymphoblastic leukemia (B-ALL). However, the pharmacogenomic basis of response to blinatumomab unclear. Using genome-wide CRISPR, we comprehensively identified intrinsic factors sensitivity, i.e., loss

10.1126/sciadv.add6403 article EN cc-by-nc Science Advances 2022-12-14

Clerodendranthus spicatus Thunb. (Labiatae) (CS), a perennial traditional Chinese medicinal herb that can reduce serum uric acid (sUA) levels and ameliorate renal function is widely used to treat hyperuricaemic nephropathy (HN).To investigate the molecular mechanism of action CS in HN treatment using vivo vitro experiments.Sprague-Dawley rats were randomly divided into control, HN, positive control allopurinol groups. The group was intraperitoneally injected with 750 mg/kg oxonic potassium...

10.1080/13880209.2023.2243086 article EN cc-by Pharmaceutical Biology 2023-08-21

Abstract Phosphorylation proteomics is the basis for study of abnormally activated kinase signaling pathways in breast cancer, which facilitates discovery new oncogenic agents and drives potential targets early diagnosis therapy cancer. In this study, we have explored aberrantly active kinases cancer development to elucidate role PRKCD_pY313 triple negative (TNBC) progression. We collected 47 pairs paired far-cancer normal tissues analyzed phosphorylated tyrosine (pY) peptides by Superbinder...

10.1186/s12964-024-01487-z article EN cc-by Cell Communication and Signaling 2024-02-12

Searching for natural products with antitumor and immune-enhancing activities is an important aspect of cancer research.

10.3390/molecules26247559 article EN cc-by Molecules 2021-12-13
Coming Soon ...